 | Up a level |
Juillerat, P; Schneeweiss, S; Cook, E F; Ananthakrishnan, A N; Mogun, H; Korzenik, J R (2012). Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Alimentary pharmacology & therapeutics, 36(3), pp. 239-47. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2012.05173.x
Juillerat, P; Schneeweiss, S; Mogun, H; Cook, EF; Ananthakrishnan, AN; Korzenik, JR (2011). New H2-eceptor Antagonist Use May Increase Risk of Surgery or Hospitalization in Crohn's Disease While PPI Use May Be Associated With Ulcerative Colitis Flares. Differential Effects of Acid Suppressing Agents in IBD. In: Digestive Disease Week.
Juillerat, P; Schneeweiss, S; Cook, F; Ananthakrishnan, A; Mogun, H; Korzenik, J (2011). Gastric Acid Inhibiting Medications May Alter The Course Of Inflammatory Bowel Disease. In: 19th United European Gastroenterology Week (UEGW). Stockholm, Sweden. October 22-26, 2011.
